138 related articles for article (PubMed ID: 36763128)
1. Exosomal lincROR Promotes Docetaxel Resistance in Prostate Cancer through a β-catenin/HIF1α Positive Feedback Loop.
Jiang X; Xu Y; Liu R; Guo S
Mol Cancer Res; 2023 May; 21(5):472-482. PubMed ID: 36763128
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
Xue D; Lu H; Xu HY; Zhou CX; He XZ
J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance.
Martinez SR; Elix CC; Ochoa PT; Sanchez-Hernandez ES; Alkashgari HR; Ortiz-Hernandez GL; Zhang L; Casiano CA
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108293
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer.
Babasaki T; Sentani K; Sekino Y; Kobayashi G; Thang Pham Q; Katsuya N; Akabane S; Taniyama D; Hayashi T; Shiota M; Oue N; Teishima J; Matsubara A; Yasui W
Cancer Med; 2021 Aug; 10(16):5574-5588. PubMed ID: 34240817
[TBL] [Abstract][Full Text] [Related]
5. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
Li Y; Zhang B; Xiang L; Xia S; Kucuk O; Deng X; Boise LH; Dong JT
Theranostics; 2020; 10(17):7656-7670. PubMed ID: 32685011
[TBL] [Abstract][Full Text] [Related]
6. Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway.
Tan X; Song X; Fan B; Li M; Zhang A; Pei L
Anticancer Drugs; 2022 Oct; 33(9):871-882. PubMed ID: 36136987
[TBL] [Abstract][Full Text] [Related]
7. ATM/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer.
Wang Z; Zhang X; Li W; Su Q; Huang Z; Zhang X; Chen H; Mo C; Huang B; Ou W; Chen J; Zhao G; Chen L; Shao L
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301812
[TBL] [Abstract][Full Text] [Related]
8. Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism.
Chen L; Song Y; Hou T; Li X; Cheng L; Li Y; Xing Y
J Exp Clin Cancer Res; 2022 Jun; 41(1):194. PubMed ID: 35659274
[TBL] [Abstract][Full Text] [Related]
9. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.
Zhang H; Li M; Zhang J; Shen Y; Gui Q
Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer.
Zhang W; Xin J; Lai J; Zhang W
Immunobiology; 2022 Jan; 227(1):152163. PubMed ID: 34896914
[TBL] [Abstract][Full Text] [Related]
11. [Role of beta-catenin signaling pathway in EMT of human prostate cancer induced by HIF-1alpha].
Luo Y; He DL; Jiang YG; Ning L; Shen SL; Zhao JH; Cui XH
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1131-6. PubMed ID: 20646434
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic ER stress suppresses β-catenin expression and promotes cooperation between the transcription factors XBP1 and HIF1α for cell survival.
Xia Z; Wu S; Wei X; Liao Y; Yi P; Liu Y; Liu J; Liu J
J Biol Chem; 2019 Sep; 294(37):13811-13821. PubMed ID: 31350332
[TBL] [Abstract][Full Text] [Related]
13. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway.
Sun CC; Zhu W; Li SJ; Hu W; Zhang J; Zhuo Y; Zhang H; Wang J; Zhang Y; Huang SX; He QQ; Li DJ
Genome Med; 2020 Sep; 12(1):77. PubMed ID: 32878637
[TBL] [Abstract][Full Text] [Related]
14. Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancer.
Li SY; Shi CJ; Fu WM; Zhang JF
J Pharm Pharmacol; 2023 Jan; 75(1):129-138. PubMed ID: 36130331
[TBL] [Abstract][Full Text] [Related]
15. Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia.
Xi Y; Wei Y; Sennino B; Ulsamer A; Kwan I; Brumwell AN; Tan K; Aghi MK; McDonald DM; Jablons DM; Chapman HA
Oncogene; 2013 Oct; 32(42):5048-57. PubMed ID: 23246962
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway.
Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G
Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522
[TBL] [Abstract][Full Text] [Related]
17. Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer.
Qian S; Zhang S; Wu Y; Ding Y; ; Li X
Chemotherapy; 2020; 65(5-6):125-133. PubMed ID: 33238278
[TBL] [Abstract][Full Text] [Related]
18. HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells.
Marhold M; Tomasich E; El-Gazzar A; Heller G; Spittler A; Horvat R; Krainer M; Horak P
Mol Cancer Res; 2015 Mar; 13(3):556-64. PubMed ID: 25349289
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines.
Linke D; Donix L; Peitzsch C; Erb HHH; Dubrovska A; Pfeifer M; Thomas C; Fuessel S; Erdmann K
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614114
[TBL] [Abstract][Full Text] [Related]
20. Activated Wnt/β-Catenin signaling contributes to E3 ubiquitin ligase EDD-conferred docetaxel resistance in prostate cancer.
Bian P; Dou Z; Jia Z; Li W; Pan D
Life Sci; 2020 Aug; 254():116816. PubMed ID: 31472148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]